Charles Halasz is a Dermatology physician affiliated with Norwalk Hospital. OpenAlex indexes 33 publications with 530 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
149 East Ave
Suite 20
Norwalk, CT 068515711
Telephone
203-853-1874Provider last certified this registry record 7 Jun 2024.
Industry payments
40 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- The Daavlin Distributing CoProgram year20251 payment
- UCB, Inc.Program year202514 payments
- ABBVIE INC.Program year202533 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
27.1%Corticosteroid9.2%Triamcinolone Acetonide100%Part D≥56 patientsVitamin D Analog6.3%Calcipotriene100%Part D≥20 patients+ 5 more classes in this area
Anti-infectives
25.1%Azole Antifungal15.9%Ketoconazole100%Part D≥71 patientsTetracycline-class Drug2.8%Doxycycline Monohydrate100%Part D≥20 patients+ 3 more classes in this area
Respiratory
19.8%Corticosteroid16.1%Mometasone Furoate100%Part D≥117 patientsRNA Synthetase Inhibitor Antibacterial3.7%Mupirocin100%Part D≥29 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Upadacitinib for Pyoderma Gangrenosum: A Case Report and Review of Emerging Evidence
SKIN The Journal of Cutaneous Medicine
2025 - Clue to Diagnosis: Flagellate Erythema in Anti-MDA5 Antibody-Positive Dermatomyositis in a Patient with Skin of Color
SKIN The Journal of Cutaneous Medicine
2025 - When the Skin Remembers: A Delayed Reaction to Corticosteroid Injection
SKIN The Journal of Cutaneous Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Patrick Reville, MD
Norwalk Hospital
Amy Ahasic, MD, MPH
Norwalk Hospital
Ian Weir, DO
Norwalk Hospital
Ming-Ming Lee, MD
Norwalk Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”